Enhancing global access to cancer medicines

Area of Science:

• Oncology
• Global Health
• Health Economics

Background:

• Cancer is a leading global cause of death, surpassing combined deaths from HIV/AIDS, tuberculosis, and malaria.
• Significant disparities in cancer survival exist between and within countries, often linked to limited access to diagnosis, treatment, and quality care.

Purpose of the Study:

• To examine factors impeding access to essential cancer medicines globally.
• To discuss strategies for improving access to and optimizing the use of cancer medicines.

Main Methods:

• Review of factors affecting access to cancer medicines, including cost, infrastructure, regulation, and supply chain reliability.
• Discussion of potential strategies such as universal health coverage, revised pricing models, reduced development costs, and optimized therapy schedules.

Main Results:

• Essential cancer medicines face barriers like high cost, inappropriate use, weak infrastructure, and quality concerns, even when listed nationally.
• Optimizing therapy schedules and utilizing biomarkers can improve efficacy and reduce adverse events.
• Effective cancer care relies on integrated services including laboratory, imaging, surgery, and radiotherapy.

Conclusions:

• Addressing cancer medicine access requires a multi-faceted approach involving policy changes, economic reforms, and infrastructure investment.
• Investment in supportive services, technology, and healthcare workforce training is crucial for equitable cancer care.
• Improved access to and optimal use of cancer medicines are essential to reduce global cancer disparities.